Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sandra Pennisi"'
Autor:
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Florian Scherer, Robert Zeiser, Justus Duyster, Hartmut Bertz, Jürgen Finke, Jesús Duque-Afonso
Publikováno v:
Cancers, Vol 14, Iss 14, p 3307 (2022)
Relapse of the underlying disease is a frequent complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In this study, we describe the clinical utility of measurable residual disease (MRD) and mixed chimerism (MC) assessmen
Externí odkaz:
https://doaj.org/article/d047753c329d43b2bb438c28646cefe1
Autor:
Florian Scherer, Max Deuter, Nikolas von Bubnoff, Sandra Pennisi, Jesus Duque-Afonso, Miguel Waterhouse, Hartmut Bertz, Jürgen Finke, Dietmar Pfeifer, Justus Duyster, Claudia Wehr, Tim Strüssmann
Publikováno v:
Bone Marrow Transplantation
Cell-free DNA (cfDNA) has been investigated in acute graft-versus-host disease (aGvHD) following allogeneic cell transplantation (HSCT). Identifying the tissue of origin of cfDNA in patients with aGvHD is relevant particularly when a biopsy is not fe
Autor:
Claudia Waskow, Robert A.J. Oostendorp, Christine Dierks, Anna Lena Illert, Alina Rudorf, Anabel Zwick, Claudius Klein, Marie Follo, Justus Duyster, Sandra Kissel, Ralph Wäsch, Sandra Pennisi, Dietmar Pfeifer, Sarah Decker, Tony Andreas Müller, Benjamin Rister
Publikováno v:
Leukemia. 33:1296-1301
Autor:
Marc Artinger, Véronique Orian-Rousseau, Lisa Pleyer, Fritz Aberger, Suzana Tesanovic, Elisabeth Bayer, Daniel Neureiter, Andrea Härzschel, Valerie Durand-Onayli, Tanja Rieß, Jan Philip Höpner, Alexandre Chigaev, Georg Auer, Julia Christine Gutjahr, Nadja Zaborsky, Richard Greil, Daniel F. Legler, Julia M. Laufer, Sandra Pennisi, Astrid Salmhofer, Xiaobing Yu, Andrea Ramspacher, Tanja Nicole Hartmann, Theresa Haslauer, Eva Szenes
Publikováno v:
Haematologica, 106 (8), 2102-2113
Haematologica
Haematologica
Adhesive properties of leukemia cells shape the degree of organ infiltration and the extent of leukocytosis. CD44 and the integrin VLA-4, a CD49d/CD29 heterodimer, are important factors of progenitor cell adhesion in bone marrow (BM). Here, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7bde17c88e6e52bc9f73a02d5ff2aa8
https://publikationen.bibliothek.kit.edu/1000127084
https://publikationen.bibliothek.kit.edu/1000127084
Autor:
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Max Deuter, Nikolas von Bubnoff, Florian Scherer, Tim Strüssmann, Claudia Wehr, Justus Duyster, Hartmut Bertz, Jürgen Finke, Jesus Duque-Afonso
Publikováno v:
Bone Marrow Transplantation
Cell-free DNA (cfDNA) has been investigated in acute graft-versus-host disease (aGvHD) following allogeneic cell transplantation (HSCT). Identifying the tissue of origin of cfDNA in patients with aGvHD is relevant particularly when a biopsy is not fe
Autor:
Tony Andreas, Müller, Sandra, Pennisi, Anabel, Zwick, Sarah, Decker, Claudius, Klein, Benjamin, Rister, Alina, Rudorf, Sandra, Kissel, Marie, Follo, Ralph, Wäsch, Anna Lena, Illert, Dietmar, Pfeifer, Robert, Oostendorp, Claudia, Waskow, Christine, Dierks, Justus, Duyster
Publikováno v:
Leukemia. 33(5)
Autor:
Pischeli Justine, Erika Tissino, Jan Philip Höpner, Alexandre Chigaev, Alexander Egle, Sandra Pennisi, Valter Gattei, Julia Christine Gutjahr, Christine Dierks, Nadja Zaborsky, Richard Greil, Marie Follo, Eva Szenes, Andrea Härzschel, Antonella Zucchetto, Sarah Decker, Tanja Nicole Hartmann
Publikováno v:
Blood. 134:1730-1730
Introduction. Ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), has proven to be an efficient treatment for chronic lymphocytic leukemia (CLL). A distinct characteristic of ibrutinib therapy is transient lymphocytosis. Recently
Autor:
Khalid Shoumariyeh, Robert Zeiser, Sivahari P. Gorantla, Sebastian Halbach, Frederike A. Hartl, Alica J. Emhardt, Julius Wehrle, Jonas S. Jutzi, Sebastian Fuchs, Ioanna Triviai, Sandra Duquesne, Michael Hettich, Annette Schmitt-Graeff, Eliana Ruggiero, Susana Minguet, Wolfgang Melchinger, Jürgen Finke, Chiara Bonini, Nicolaus Kröger, Pia Veratti, Anna Lena Illert, Bruce R. Blazar, Melanie Boerries, Mark Bartholomä, Teresa Poggio, Geoffrey R. Hill, Steven W. Lane, Gabriele Niedermann, Petya Apostolova, Slavica Vuckovic, Nikolas von Bubnoff, Konrad Aumann, Hauke Busch, Stephan Ehl, Florian H. Heidel, Sandra Pennisi, Dietmar Pfeifer, Justus Duyster, Cornelius Miething, David O’Sullivan, Marie Follo, Lukas Braun, Christine Dierks, Heiko Becker, Heike L. Pahl, Jan Rohr, Tilman Brummer, Alessandro Prestipino, Erika L. Pearce
Publikováno v:
Science Translational Medicine
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Science translational medicine : integrating medicine and science / American Association for the Advancement of Science
Recent evidence has revealed that oncogenic mutations may confer immune escape. A better understanding of how an oncogenic mutation affects immunosuppressive programmed death ligand 1 (PD-L1) expression may help in developing new therapeutic strategi
Autor:
Alessandro, Prestipino, Alica J, Emhardt, Konrad, Aumann, David, O'Sullivan, Sivahari P, Gorantla, Sandra, Duquesne, Wolfgang, Melchinger, Lukas, Braun, Slavica, Vuckovic, Melanie, Boerries, Hauke, Busch, Sebastian, Halbach, Sandra, Pennisi, Teresa, Poggio, Petya, Apostolova, Pia, Veratti, Michael, Hettich, Gabriele, Niedermann, Mark, Bartholomä, Khalid, Shoumariyeh, Jonas S, Jutzi, Julius, Wehrle, Christine, Dierks, Heiko, Becker, Annette, Schmitt-Graeff, Marie, Follo, Dietmar, Pfeifer, Jan, Rohr, Sebastian, Fuchs, Stephan, Ehl, Frederike A, Hartl, Susana, Minguet, Cornelius, Miething, Florian H, Heidel, Nicolaus, Kröger, Ioanna, Triviai, Tilman, Brummer, Jürgen, Finke, Anna L, Illert, Eliana, Ruggiero, Chiara, Bonini, Justus, Duyster, Heike L, Pahl, Steven W, Lane, Geoffrey R, Hill, Bruce R, Blazar, Nikolas, von Bubnoff, Erika L, Pearce, Robert, Zeiser
Publikováno v:
Science translational medicine. 10(429)
Recent evidence has revealed that oncogenic mutations may confer immune escape. A better understanding of how an oncogenic mutation affects immunosuppressive PD-L1 expression may help in developing new therapeutic strategies. Here, we show that oncog